BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32986419)

  • 1. Pyrrolo[2',3':3,4]cyclohepta[1,2-
    Spanò V; Rocca R; Barreca M; Giallombardo D; Montalbano A; Carbone A; Raimondi MV; Gaudio E; Bortolozzi R; Bai R; Tassone P; Alcaro S; Hamel E; Viola G; Bertoni F; Barraja P
    J Med Chem; 2020 Oct; 63(20):12023-12042. PubMed ID: 32986419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.
    Barreca M; Spanò V; Rocca R; Bivacqua R; Gualtieri G; Raimondi MV; Gaudio E; Bortolozzi R; Manfreda L; Bai R; Montalbano A; Alcaro S; Hamel E; Bertoni F; Viola G; Barraja P
    Eur J Med Chem; 2023 Jun; 254():115372. PubMed ID: 37068384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
    Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
    Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents.
    Prasad B; Lakshma Nayak V; Srikanth PS; Baig MF; Subba Reddy NV; Babu KS; Kamal A
    Bioorg Chem; 2019 Mar; 83():535-548. PubMed ID: 30472555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-mitotic activity of 2,4- or 2,6-disubstituted- and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines.
    Milišiūnaitė V; Arbačiauskienė E; Řezníčková E; Jorda R; Malínková V; Žukauskaitė A; Holzer W; Šačkus A; Kryštof V
    Eur J Med Chem; 2018 Apr; 150():908-919. PubMed ID: 29602037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents.
    Romagnoli R; Oliva P; Salvador MK; Manfredini S; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Rruga F; Mariotto E; Viola G; Bortolozzi R
    Eur J Med Chem; 2021 Mar; 214():113229. PubMed ID: 33550186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization.
    Zhang R; Mo H; Ma YY; Zhao DG; Zhang K; Zhang T; Chen X; Zheng X
    Bioorg Med Chem Lett; 2021 May; 40():127968. PubMed ID: 33753264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells.
    Liu J; Ye W; Xu JP; Wang HT; Li XF; Wang WY; Zhou ZZ
    Eur J Med Chem; 2021 Nov; 224():113700. PubMed ID: 34311158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents.
    Kamal A; Mallareddy A; Suresh P; Shaik TB; Lakshma Nayak V; Kishor C; Shetti RV; Sankara Rao N; Tamboli JR; Ramakrishna S; Addlagatta A
    Bioorg Med Chem; 2012 Jun; 20(11):3480-92. PubMed ID: 22543234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
    Kamal A; Balakishan G; Ramakrishna G; Shaik TB; Sreekanth K; Balakrishna M; Rajender ; Dastagiri D; Kalivendi SV
    Eur J Med Chem; 2010 Sep; 45(9):3870-84. PubMed ID: 20554354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2-anilinopyridyl-triazole conjugates as antimitotic agents.
    Kamal A; Subba Rao AV; Vishnuvardhan MV; Srinivas Reddy T; Swapna K; Bagul C; Subba Reddy NV; Srinivasulu V
    Org Biomol Chem; 2015 May; 13(17):4879-95. PubMed ID: 25765224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 6H-pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5(6H)-ones as antimitotic agents and inhibitors of tubulin polymerization.
    Meng T; Wang W; Zhang Z; Ma L; Zhang Y; Miao Z; Shen J
    Bioorg Med Chem; 2014 Jan; 22(2):848-55. PubMed ID: 24360827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
    Kamal A; Suresh P; Mallareddy A; Kumar BA; Reddy PV; Raju P; Tamboli JR; Shaik TB; Jain N; Kalivendi SV
    Bioorg Med Chem; 2011 Apr; 19(7):2349-58. PubMed ID: 21402478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel.
    França F; Silva PMA; Soares JX; Henriques AC; Loureiro DRP; Azevedo CMG; Afonso CMM; Bousbaa H
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Developments on Phenstatins as Potent Antimitotic Agents.
    Chen X; Wang SM; Kumar GB; Bare GAL; Leng J; Bukhari SNA; Qin HL
    Curr Med Chem; 2018; 25(20):2329-2352. PubMed ID: 29110592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis of 2-aryl 5-hydroxy benzo[d]oxazoles and their in vitro anti-proliferative effects on various cancer cell lines.
    Tangellamudi ND; Shinde SB; Pooladanda V; Godugu C; Balasubramanian S
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3639-3647. PubMed ID: 30389295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KSP inhibitors as antimitotic agents.
    Pérez-Melero C
    Curr Top Med Chem; 2014; 14(20):2286-311. PubMed ID: 25434354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of Selenium-Containing 4-Anilinoquinazoline Derivatives as Novel Antimitotic Agents.
    An B; Wang B; Hu J; Xu S; Huang L; Li X; Chan ASC
    J Med Chem; 2018 Mar; 61(6):2571-2588. PubMed ID: 29509413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
    Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
    Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of aryloxazole derivatives as antimitotic and vascular-disrupting agents for cancer therapy.
    Choi MJ; No ES; Thorat DA; Jang JW; Yang H; Lee J; Choo H; Kim SJ; Lee CS; Ko SY; Lee J; Nam G; Pae AN
    J Med Chem; 2013 Nov; 56(22):9008-18. PubMed ID: 24160376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.